This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell 5.28 points to 990.62 Monday. John O'Sullivan and Don Wright's halted capital pool shell, Cinaport Acquisition Corp. (CPQ), expects to complete its acquisition of Mettrum Ltd., a licensed producer of medical marijuana, within a month. It will likely be the third licensed producer to go public. Chuck Rifici's Tweed Marijuana Inc. (TWD: $2.64), which listed on the TSX-V last April, was the first. Marc Wayne's Bedrocan Canada Inc., which has an agreement to go public through Pat DiCapo's POCML 2 Inc. (PCC), will probably be the second. A filing statement about the Bedrocan deal is already on SEDAR and the licensed producer anticipates listing either this week or next week under symbol BED. Denis Arsenault's OrganiGram Ltd. is another licensed producer that will list shortly.

Cinaport plans to roll back its shares 1:14.5625 and then issue 19,416,200 postconsolidated shares to the target's shareholders. As well, Mettrum recently closed a $34.5-million private placement of 13.8 million subscription receipts at $2.50 a receipt. Those receipts will convert into units of Mettrum at a ratio of 1:1 following the qualifying transaction, with each unit comprising one share and one warrant, exercisable at $3.50 for 12 months from listing. Just three of the subscribers to that financing are funds registered in British Columbia, the largest of which was Ryaz Shariff's Primevest Fund, which spent $1-million on 400,000 receipts. Two of the other funds, both managed by portfolio manager Bruce Campbell, were Redwood Equity Growth Fund, which spent $146,250 on 58,500 receipts, and Stone Castle Fund, which spent $53,750 on 21,500 receipts.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS